Pharmafile Logo
Pharmafocus logo
Advanced Search

Recruitment

Showing 15 posts of 17 posts found.

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026 Clinical trials supplies & documentation logistics, Due Diligence, NICE / SMC Submissions, Pharmacovigilance, Regulatory Affairs Oncology

By Chloe Williams and Sarah Ellson Innovative therapies are transforming the treatment landscape for serious diseases, particularly cancer. Advances in …
Feature

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026 Clinical & Scientific, Clinical Research, Clinical Trial Services, Clinical research Training, Clinical trial specialist packaging, Data Capture Asthma & COPD, Chronic Diseases, Immunology, Rare Diseases, Sample integrity, clinical trials, enrolment

By Dr. Richard Graham Industry conversations about clinical trial participation tend to focus on awareness, access, and willingness to enrol. …
Feature

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026 Licences/Quality Standards, Packaging, Pharmacovigilance Contamination Control, Devices, inspection, pharmaceutical manufacturing, regulatory

By Adam Green In pharmaceutical manufacturing, inspection plays a critical role in process control to examine individual products, primary packs, …
Feature

Halma acquires pathology automation specialist Dreampath

July 9, 2026 Business Development Dreampath, Halma

Halma has agreed to acquire French diagnostics company Dreampath in a deal that will expand its pathology portfolio and strengthen …
News

Sandoz opens biosimilar development centre in Slovenia

June 19, 2026 Business Development Sandoz, biosimilar development

Sandoz has opened a new biosimilar development centre in Ljubljana, Slovenia, as part of efforts to expand its in-house capabilities …
News

Hansa Biopharma appoints Fredrik Röök as VP Business Development

June 11, 2026 Business Development Hansa Biopharma

Hansa Biopharma has announced that Fredrik Röök has been appointed as VP Business Development, as of 17 August. Röök will …
Appointment

Endometriosis study begins recruitment in UK hospitals

May 28, 2026 Clinical Research, Recruitment Cyclana Bio, endometriosis

Cyclana Bio has recruited the first patients into a 500-participant observational study investigating the biological mechanisms behind endometriosis, following approval …
News

The Pharma Files: With Priyanka Hinton from CHASE

August 3, 2025 Business Services, Recruitment CHASE, The Pharma Files

Pharmafile chats with Priyanka Hinton, Customer Solutions Director at Chase People about the best parts of her job and her …
Feature

Apiary invests in life sciences SEO pioneer PIO to support global expansion

May 9, 2025 Agency, Business Services, Marketing Consultancies AI, Apiary Capital, Corporate, PIO, SEO, agency, investment, performance marketing, performance-io

Private equity firm Apiary Capital has invested in performance-io (PIO), a specialist life sciences performance marketing and SEO agency, to …
News

Neurizon makes appointments to executive team

April 24, 2025 Recruitment, Senior Management Neurizon, Neurology, als, biotech, neurodegenerative diseases

Neurizon Therapeutics, a clinical-stage biotech company focusing on treatments for neurodegenerative diseases, has announced three leadership appointments. These will support …
Appointment

AAX Biotech aims to enhance growth with two new appointments

April 10, 2025 Business Development, Recruitment, Research and Development AAX Biotech, Immunology, Oncology, R&D development, antibody therapeutics, business development

AAX Biotech has appointed Ionut Gabriel Dumitru (pictured left) as senior scientist and Kushal Sejwal (pictured right) as business developer, …
Appointment

Shane Olwill appointed as chief development officer at Asgard Therapeutics

March 28, 2025 Business Services, Clinical Research Asgard Therapeutics, CDO, Oncology, appointment, immunology

Asgard Therapeutics has announced the appointment of Shane Olwill as chief development officer (CDO). The biotech company develops in vivo …
Appointment

PulseSight Therapeutics closes Series A financing for dry AMD phase 1 clinical study

February 14, 2025 Clinical Research Opthalmology, age-related macular degeneration, clinical trials

Ophthalmology biotech PulseSight Therapeutics has confirmed the closure of its Series A funding round, the proceeds of which will be …
News

Results from Novadip phase 1b/2a trial reveal 88% efficacy

January 28, 2025 Clinical Research Congenital Pseudoarthritis of the Tibia, Rare Diseases, clinical trials, efficacy, paediatric, rare diseases

Novadip Biosciences, a clinical stage biotechnology company with a specialty in regenerative medicine, has announced the results of its 12-month …
News

China CDE clears Phase 3 Study of Lisafltoclax in Newlly Diagnosed Patients with Higher-Risk Myelodysplastic Syndrome

August 13, 2024 Clinical Research, Research and Development Ascentage Pharma, Oncology

The China Centre for Drug Evaluation (CDE) has cleared the registrational phase 3 study of lisaftoclax in combination with azacitadine …
News
The Gateway to Local Adoption Series

Latest content

From lab breakthrough to NHS treatment: Getting innovative therapies to patients

September 5, 2026

Five Facts about NHS and primary care

September 5, 2026

Clinical trials don’t just have a recruitment problem, they have an enrolment protection problem.

September 5, 2026

AI in pharma: From lab development to patient impact

September 5, 2026

Back to basics: X-ray inspection in pharmaceutical and medical device production

September 5, 2026